Rapid deployment valves versus conventional tissue valves for aortic valve replacement

Area of Science:

• Cardiovascular Surgery
• Medical Devices
• Heart Valve Disease

Background:

• Rapid deployment valves (RDVs) were developed to address limitations in transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR).
• Existing studies indicate RDVs shorten SAVR but provide no clear clinical advantage.

Purpose of the Study:

• To compare the clinical outcomes of RDVs versus conventional sutured aortic valve replacement.
• To evaluate the efficacy and safety of rapid deployment valves in aortic valve disease management.

Main Methods:

• Retrospective review of 2237 patients undergoing tissue aortic valve replacement (2013-2019).
• Patients divided into RDV and conventional sutured valve groups.
• Inverse probability treatment weighting (IPTW) used for cohort matching.
• Kaplan-Meier curves and log-rank tests analyzed outcomes, including all-cause mortality at 30 days, 1 year, and 5 years.

Main Results:

• IPTW resulted in 295 patients per group with similar baseline characteristics.
• RDVs were associated with shorter cardiopulmonary bypass and crossclamp times.
• No significant difference in primary or secondary outcomes (all-cause mortality) was observed.
• A significantly higher rate of permanent pacemaker insertion (7%) was noted in the RDV group (P < .009).

Conclusions:

• RDVs offer no discernible benefit for standard aortic valve replacement procedures.
• Further investigation is required to determine specific patient populations for whom RDVs may be beneficial.
• The increased need for permanent pacemaker insertion with RDVs warrants consideration.